Project Grant HT9425261E121
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $700K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
- Federal Project Grant Award Summary The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $750,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective March 1, 2026, through February 28, 2029. The research initiative focuses on targeting KDM1A/LSD1 (lysine-specific demethylase 1) to overcome radiation resistance in triple-negative breast cancer brain metastases. This three-year research...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,049,994 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research investigating the therapeutic potential of detecting and inhibiting cytosolic ADP-ribosylation in ovarian cancer. This three-year research initiative aligns with the Military Medical...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $349,976 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2028. The award funds research focused on intercepting omental metastasis of ovarian cancer through targeting a mitochondrial redox-interleukin-10 (IL-10) axis in the immune microenvironment. This research initiative...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $1.476 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on August 15, 2025, with a completion date of August 14, 2028. This award supports the development and research of an in situ tumor vaccine designed to stimulate antitumor immunity against breast cancer. The three-year project will be conducted at UT...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded UC San Diego a $1.65 million project grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026, through April 30, 2029. The award supports research focused on targeting oncoembryonic antigens to overcome therapy resistance in patients with triple-negative breast cancer. This research initiative represents a translational oncology effort within the DHA's broader portfolio of...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $323,700 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. This award supports research utilizing enhancer CRISPR screening to identify PLXNA1 as a critical regulator in clear cell renal cell carcinoma (ccRCC). The research represents a translational science initiative aligned...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $817,496 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award funds research to investigate the PRMT3-IGF2BP1 axis-mediated epitranscriptomic reprogramming as a novel therapeutic strategy to overcome immunotherapy resistance in clear cell renal cell carcinoma...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $319,800 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The award funds research on novel hypoxia-inducible factor 2 (HIF-2) regulators and therapeutic targets for kidney cancer, conducted at the institution's Dallas, Texas campus. This research initiative...
- The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
- Federal Grant Award Summary The University of Texas MD Anderson Cancer Center received a $1.35 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the three-year period from October 1, 2025, through September 30, 2028. The award funds research focused on building T-cell products for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors (MPNST) through antigen discovery and...